Ozagrel Sodium is a thromboxane A₂ synthase inhibitor, mainly used for its antiplatelet and vasodilatory effects. It’s mainly available and used in Japan and a few other countries, often in neurological and cardiovascular conditions. It is grouped under the following drug class(es): Antiplatelets. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Athrombone, Kadenin and Xanbon. Its PubChem CID is 23663942.
Ozagrel sodium
| CAS No | 189224-26-8 |
|---|---|
| Molecular Formula | C13H11N2NaO2 |
| Molecular Weight | 250.23 g/mol |
| Synonyms | sodium;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ozagrel Sodium is a thromboxane A₂ synthase inhibitor, mainly used for its antiplatelet and vasodilatory effects. It’s mainly available and used in Japan and a few other countries, often in neurological and cardiovascular conditions.
The listed CAS number is 189224-26-8.
The listed molecular formula is C13H11N2NaO2.
The listed molecular weight is 250.23 g/mol.
sodium;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate.
The source lists Athrombone, Kadenin and Xanbon.